- Bertrand Routy
- 18-Oct-2018
- 14.30 - 15.00
Gut microbiota in immuno-oncology; from discovery to clinical trials
The objective is to use the gut microbiome has a novel biomarker of ICI response and to manipulate the microbiome to enhance ICI anti-cancer activity.